Quick Answer
BRAINSTORM CELL THERAPEUTICS INC. reported Common Stock Shares Outstanding of 11.03 million shares for the year ending 2025.
- BRAINSTORM CELL THERAPEUTICS INC. showed an increase of +79.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BRAINSTORM CELL THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2004: 10.24 million shares | Q3 2011: 125.62 million shares | Q1 2012: 126.74 million shares | Q3 2012: 150.09 million shares | Q1 2013: 151.85 million shares | Q2 2013: 152.71 million shares | Q3 2013: 176.24 million shares | Q1 2014: 176.80 million shares | Q2 2014: 225.47 million shares | Q3 2014: 15.23 million shares | Q1 2015: 18.39 million shares | Q2 2015: 18.48 million shares | Q3 2015: 18.48 million shares | Q1 2016: 18.65 million shares | Q2 2016: 18.65 million shares | Q3 2016: 18.69 million shares | Q1 2017: 18.70 million shares | Q2 2017: 18.75 million shares | Q3 2017: 18.84 million shares | Q1 2018: 19.11 million shares | Q2 2018: 20.67 million shares | Q3 2018: 20.70 million shares | Q1 2019: 21.49 million shares | Q2 2019: 21.71 million shares | Q3 2019: 22.61 million shares | Q1 2020: 28.42 million shares | Q2 2020: 29.67 million shares | Q3 2020: 31.57 million shares | Q1 2021: 36.32 million shares | Q2 2021: 36.32 million shares | Q3 2021: 36.28 million shares | Q1 2022: 36.49 million shares | Q2 2022: 36.49 million shares | Q3 2022: 36.54 million shares | Q1 2023: 38.48 million shares | Q2 2023: 40.93 million shares | Q3 2023: 45.31 million shares | Q1 2024: 68.45 million shares | Q2 2024: 79.65 million shares | Q3 2024: 5.31 million shares | Q1 2025: 7.91 million shares | Q2 2025: 10.12 million shares | Q3 2025: 11.03 million shares.
- Over the full 16 years of available data (2010 to 2025), BRAINSTORM CELL THERAPEUTICS INC.'s Common Stock Shares Outstanding has declined by 88.5%.
- Historical annual values: Fiscal year 2025: 11.03 million shares | Fiscal year 2024: 6.14 million shares | Fiscal year 2023: 4.03 million shares | Fiscal year 2022: 36.69 million shares | Fiscal year 2021: 36.40 million shares | Fiscal year 2020: 35.16 million shares | Fiscal year 2019: 23.17 million shares | Fiscal year 2018: 20.76 million shares | Fiscal year 2017: 18.98 million shares | Fiscal year 2016: 18.69 million shares | Fiscal year 2015: 18.64 million shares | Fiscal year 2014: 15.28 million shares | Fiscal year 2013: 11.75 million shares | Fiscal year 2012: 150.09 million shares | Fiscal year 2011: 126.44 million shares | Fiscal year 2010: 95.83 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: